| Literature DB >> 32019391 |
Andrea Genazzani1, Nick Panay2, Tommaso Simoncini3, Herman Depypere4, Alfred Mueck5,6, Christian Egarter7, Nicoletta Biglia8, Tomas Fait9, Martin Birkhaeuser10, Sven O Skouby11, Mark Brincat12, Steven Goldstein13, Xiangyan Ruan5,6, Cuauhtémoc Celis-Gonzales14, Santiago Palacios15.
Abstract
Research into non-hormonal, alternative therapies is necessary for women for whom menopausal hormone therapy is contraindicated or for women who do not wish to take hormones. This review focuses on one such non-hormonal option, namely, purified and specific cytoplasmic pollen extract, or PureCyTonin®. This extract has been evaluated in several preclinical and clinical studies, where it demonstrated its value as a safe and non-estrogenic alternative for menopause. This review presents the beneficial effects of PureCyTonin® in the treatment of menopausal symptoms (e.g. hot flushes) in healthy women, as well as in premenstrual syndrome. We discuss the mechanism of action of PureCyTonin®, an SSRI-'like' therapy. The lack of estrogenic effect demonstrated in preclinical studies suggests that PureCyTonin® may also be a suitable option for the management of menopausal symptoms in women with breast cancer.Entities:
Keywords: PureCyTonin®; Purified and specific cytoplasmic pollen extract; Serelys®; hot flushes; menopause; non-hormonal alternative; premenstrual syndrome
Year: 2020 PMID: 32019391 DOI: 10.1080/09513590.2020.1722994
Source DB: PubMed Journal: Gynecol Endocrinol ISSN: 0951-3590 Impact factor: 2.260